SCHEMBL7445925

SCHEMBL7445925

O=C(Cl)O[C@H]1CCCCC(OC(=O)N2CCN(C(=O)OCc3ccccc3)CC2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.57
NPC1 O15118 2/20 0.57
RAB9A P51151 2/20 0.57
F2 P00734 1/20 0.57
PRSS1 P07477 1/20 0.57
CYP2C19 P33261 1/20 0.55
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
PDE4B Q07343 1/20 0.48
GRIN2B Q13224 5/20 0.47
HTT P42858 1/20 0.47
OPRD1 P41143 1/20 0.47
OPRK1 P41145 1/20 0.47
TPSAB1 Q15661 2/20 0.47
TPSD1 Q9BZJ3 2/20 0.47
TPSG1 Q9NRR2 2/20 0.47
CYP2D6 P10635 2/20 0.47
CYP2C9 P11712 2/20 0.47
ALDH1A1 P00352 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL953680 0.91 PRSS1 (0.67) SMN1; SMN2NPC1RAB9AF2PRSS1
SCHEMBL9691141 0.90 SMN1; SMN2 (0.67) SMN1; SMN2NPC1RAB9AF2PRSS1
SCHEMBL4285600 0.81 SMN1; SMN2 (0.62) SMN1; SMN2NPC1RAB9AF2PRSS1
SCHEMBL379160 0.80 MEN1 (0.76) SMN1; SMN2NPC1RAB9ACYP2C19MEN1
SCHEMBL3970912 0.80 MEN1 (0.76) SMN1; SMN2NPC1RAB9ACYP2C19MEN1
SCHEMBL7393652 0.80 MEN1 (0.76) SMN1; SMN2NPC1RAB9ACYP2C19MEN1
SCHEMBL4814264 0.80 MEN1 (0.76) SMN1; SMN2NPC1RAB9ACYP2C19MEN1
SCHEMBL2306313 0.79 SMN1; SMN2 (0.70) SMN1; SMN2NPC1RAB9ACYP2C19MEN1
SCHEMBL16669593 0.79 MEN1 (0.76) SMN1; SMN2NPC1RAB9AF2PRSS1
SCHEMBL16669380 0.79 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9ACYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0934293-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH TRYPTASE ACTIVITY ARRIS PHARMACEUTICAL CORPORATION (US) 1999-08-11 EP disclosed
WO-1998004537-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH TRYPTASE ACTIVITY ARRIS PHARMACEUTICAL CORPORATION (US) 1998-02-05 WO disclosed